Life360 Inc SEC Filings

Life360, Inc. reporting person Lauren Antonoff, who serves as Chief Executive Officer and a director, received a grant of 52,997 restricted stock units (RSUs) on 09/01/2025. Each RSU converts to one share upon settlement and the grant vests monthly at a rate of 1/48th beginning September 1, 2025, subject to continued service. Following the grant, the filing reports 356,229 shares/RSU-equivalents beneficially owned, which includes 258,971 previously granted RSUs. The acquisition was recorded at a $0 price (typical for RSU grants). The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Life360 director Chris Hulls received a grant of 26,499 restricted stock units (RSUs) that vest monthly over four years. Each RSU converts into one share upon settlement and 1/48th vests monthly beginning 09/01/2025, subject to continuous service. After the grant the reporting person beneficially owns 483,830 shares (including previously granted RSUs).

The filing discloses 151,934 previously granted RSUs, ownership through three family irrevocable trusts and a minority interest in ICCA Labs, LLC, and that 585,938 CDIs remain subject to a lock-up agreement.

Life360, Inc. (LIF) director Mark Goines received a grant of 189 Restricted Stock Units (RSUs) on 09/01/2025. Each RSU vests into one share on settlement; one-third vests on November 15, 2025, and the remaining two-thirds vest in equal quarterly installments thereafter, subject to continuous service. The reported RSUs were granted at a $0 price. After the reported transaction, the filing shows 6,070 shares beneficially owned directly and 71,809 shares held indirectly by the Goines Wong Living Trust. The filing also notes 3,055 previously granted RSUs included in the totals.

Life360, Inc. (LIF) Form 4: This filing reports insider transactions by John Burke Russell, identified as the companys Chief Financial Officer. On 08/26/2025 the reporting person sold 16,287 shares of common stock at a weighted-average price of $90.42 per share (individual trade prices ranged from $90.07 to $90.72). After the sale, the filing shows 63,030 shares beneficially owned indirectly, held by the Russell John Burke Revocable Trust. The filing also notes a prior transfer of 79,317 directly held shares to that trust, which the filer states was exempt from Section 16 under Rule 16a-13. Additionally, 111,231 restricted stock units remain recorded as contingent rights to receive common stock upon vesting. The form is signed by Allison Chang, Attorney-in-Fact, dated 08/28/2025.

Life360 insider sale by CEO/director Lauren Antonoff. The filing shows Ms. Antonoff sold 4,546 shares of Life360 common stock on 08/25/2025 at $90 per share under a pre-established Rule 10b5-1 trading plan adopted 11/27/2024. After the sale, she beneficially owns 303,232 shares, which includes 205,974 restricted stock units that convert to common shares upon vesting. The Form 4 was signed by an attorney-in-fact on 08/27/2025. The filing states the 10b5-1 plan was adopted when the reporting person was unaware of any material nonpublic information.

Mark Goines, a director of Life360, Inc. (LIF), sold 20,000 shares of the company's common stock on 08/22/2025 at a weighted average price of $86.87 per share (sales ranged $86.87–$86.93). After the sale and related transfers, the reporting person beneficially owns 71,809 shares, held indirectly through the Goines Wong Living Trust. The filing discloses that 55,537 directly held shares were transferred to that trust in a transaction exempt under Rule 16a-13, and that 2,866 restricted stock units remain contingent rights to receive shares upon vesting.

Life360, Inc. (LIF) Form 4 shows Russell John Burke, the company's Chief Financial Officer and a Director, reported a transaction dated 08/22/2025. The filing discloses a gift of 5,870 shares of common stock to a donor-advised fund; the shares were donated (code G(1)) at a price of $0 and the reporting person "retains no beneficial ownership or control" of the donated securities after the contribution.

The reporting person is shown as beneficially owning 190,548 shares following the transaction, which the filing notes includes 111,231 restricted stock units that convert to shares upon vesting. The form was signed by an attorney-in-fact on 08/26/2025.

Form 144 filed for Life360, Inc. (LIF): The filing notifies a proposed sale of 16,287 shares of common stock to be executed through Charles Schwab on 08/26/2025 on NASDAQ with an aggregate market value of $1,477,556.00. The seller previously acquired shares via equity awards on 08/19/2024 (11,100 shares), 03/27/2025 (1,541 shares), and 06/05/2025 (3,646 shares), all listed as equity compensation from the issuer. The filing also reports four completed sales by Russell John Burke in the past three months totaling 12,342 shares for gross proceeds of $820,333.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Life360, Inc. (LIF) Form 144 notice reports a proposed sale of 1,858 common shares through Fidelity Brokerage Services, with an aggregate market value of $167,220, scheduled approximately for 08/26/2025. The shares were acquired on 12/02/2024 upon restricted stock vesting and were granted as compensation. The filing lists multiple sales by the same person, Susan Stick, during the prior three months totaling 10,210 shares and gross proceeds of approximately $764,008.87 across dates from 05/27/2025 to 08/25/2025. The issuer has 77,548,651 shares outstanding per the form. The filer certifies no undisclosed material adverse information and attests to the truthfulness of the notice.